News
In this week’s edition of InnovationRx, we look at Immuneering’s slow-and-steady approach to cancer fighting, litigation over ...
Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory ...
9hOpinion
Intelligencer on MSNWhy Calling RFK Jr. ‘Anti-Science’ Misses the PointKennedy Jr. and the Make America Healthy Again movement marched through that rift as they rose to power. As secretary of ...
1h
CNET on MSNThe HBO Max Name Change Is Here. Here's What to KnowYour home screen will change to reflect the streamer's updated name and logo, but it's unclear whether HBO Max's library will ...
Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?
Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's strategy to diversify beyond ...
The largest Medicaid claims processor has built a network of at least 1,800 engineers and analysts in India, rapidly ...
1h
ExtremeTech on MSNThis Tiny Elephant Figure Was 3D Printed Inside a Living CellIn a preprint paper shared via the arXiv, scientists in Slovenia announce that they managed to 3D print a tiny elephant ...
The research is a transformative step toward understanding the condition's genetic underpinnings and potential for ...
Lower-income countries, including South Africa, gain unprecedented access to lenacapavir, a revolutionary HIV prevention drug ...
The Athletic went to the town of Aberystwyth in search of a letter which was integral to the creation of Wales' women's ...
Globally, $105.3 billion worth of pharmaceuticals and biotech M&A deals have been inked so far in 2025, according to data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results